Search research articles
Contact Us
Filters
Showing results (511-520 of 518) with videos related to
Page
of 52
Sort By:
You have reached the last page of results.
This site can display upto 518 results.
The Journal of Clinical Investigation
|
December 20, 2016
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
Sophie J Bradley, Julie-Myrtille Bourgognon, Helen E Sanger, et al.
Nature Chemical Biology
|
February 22, 2020
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs
Sophie J Bradley, Colin Molloy, Paulina Valuskova, et al.
Nature
|
September 9, 2021
Positive allosteric mechanisms of adenosine A<sub>1</sub> receptor-mediated analgesia
Christopher J Draper-Joyce, Rebecca Bhola, Jinan Wang, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
<i>De novo</i> design of miniprotein agonists and antagonists targeting G protein-coupled receptors
Edin Muratspahić, David Feldman, David E Kim, et al.
Cell
|
November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease
Alastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Nature
|
May 21, 2026
De novo design of miniproteins targeting GPCRs
Edin Muratspahić, David Feldman, David E Kim, et al.
Nature Genetics
|
September 7, 2023
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Vasiliki Lagou, Longda Jiang, Anna Ulrich, et al.
British Journal of Pharmacology
|
February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overview
Stephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Page
of 52
Search research articles
Search
Showing results (511-520 of 518) with videos related to
Sort By:
Page
of 52
You have reached the last page of results.
This site can display upto 518 results.
The Journal of Clinical Investigation
|
December 20, 2016
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
Sophie J Bradley, Julie-Myrtille Bourgognon, Helen E Sanger, et al.
Nature Chemical Biology
|
February 22, 2020
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs
Sophie J Bradley, Colin Molloy, Paulina Valuskova, et al.
Nature
|
September 9, 2021
Positive allosteric mechanisms of adenosine A<sub>1</sub> receptor-mediated analgesia
Christopher J Draper-Joyce, Rebecca Bhola, Jinan Wang, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
<i>De novo</i> design of miniprotein agonists and antagonists targeting G protein-coupled receptors
Edin Muratspahić, David Feldman, David E Kim, et al.
Cell
|
November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease
Alastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Nature
|
May 21, 2026
De novo design of miniproteins targeting GPCRs
Edin Muratspahić, David Feldman, David E Kim, et al.
Nature Genetics
|
September 7, 2023
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification
Vasiliki Lagou, Longda Jiang, Anna Ulrich, et al.
British Journal of Pharmacology
|
February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overview
Stephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Page
of 52